| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,839 |
25,506 |
$4.22M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,292 |
22,085 |
$3.49M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,983 |
2,531 |
$1.25M |
| 71045 |
Radiologic examination, chest; single view |
13,255 |
8,391 |
$1.17M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
21,209 |
14,350 |
$1.04M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,823 |
2,091 |
$1.00M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,341 |
4,398 |
$753K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,487 |
8,884 |
$560K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,614 |
2,368 |
$294K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,335 |
3,815 |
$271K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,411 |
6,749 |
$250K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,608 |
3,079 |
$228K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,105 |
4,413 |
$178K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,077 |
841 |
$173K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,754 |
4,589 |
$143K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
370 |
123 |
$137K |
| 85027 |
|
46,718 |
30,261 |
$135K |
| 80053 |
Comprehensive metabolic panel |
27,818 |
17,756 |
$128K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
792 |
322 |
$107K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,984 |
4,470 |
$103K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,063 |
1,351 |
$97K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,718 |
1,824 |
$75K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
747 |
487 |
$73K |
| 11043 |
|
286 |
53 |
$69K |
| 84484 |
|
13,765 |
7,080 |
$66K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
444 |
272 |
$66K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,379 |
8,843 |
$49K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
993 |
749 |
$46K |
| 87400 |
|
3,065 |
2,144 |
$42K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,584 |
676 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
321 |
267 |
$29K |
| G0378 |
Hospital observation service, per hour |
263 |
124 |
$27K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
180 |
145 |
$26K |
| 82077 |
|
2,824 |
1,741 |
$25K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
346 |
256 |
$22K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
467 |
370 |
$21K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
584 |
499 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
164 |
98 |
$20K |
| 81025 |
|
3,483 |
2,644 |
$18K |
| 81001 |
|
12,033 |
8,619 |
$18K |
| 83690 |
|
6,497 |
4,295 |
$18K |
| 87070 |
|
3,183 |
2,525 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,546 |
1,289 |
$14K |
| 87430 |
|
1,196 |
886 |
$13K |
| 80143 |
|
1,362 |
815 |
$13K |
| 80179 |
|
1,361 |
815 |
$13K |
| 83735 |
|
4,074 |
2,682 |
$12K |
| 83880 |
|
616 |
334 |
$8K |
| 81003 |
|
6,006 |
4,098 |
$7K |
| 80076 |
|
2,181 |
1,543 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,128 |
1,636 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
2,990 |
2,562 |
$6K |
| 85379 |
|
1,279 |
705 |
$6K |
| 43249 |
|
205 |
136 |
$5K |
| 85610 |
|
2,501 |
1,443 |
$4K |
| 84703 |
|
912 |
621 |
$4K |
| 43248 |
|
32 |
26 |
$3K |
| 87040 |
|
346 |
149 |
$2K |
| 83605 |
|
442 |
182 |
$2K |
| 87420 |
|
184 |
125 |
$2K |
| 86140 |
|
623 |
327 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
242 |
193 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
56 |
54 |
$1K |
| 80061 |
Lipid panel |
188 |
147 |
$1K |
| 85730 |
|
402 |
297 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$831.36 |
| 73610 |
|
15 |
12 |
$693.43 |
| 82150 |
|
224 |
150 |
$673.92 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
47 |
37 |
$494.02 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
43 |
39 |
$465.05 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
12 |
$369.86 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
12 |
$369.86 |
| 82465 |
|
74 |
70 |
$324.81 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
13 |
$295.62 |
| 87077 |
|
52 |
36 |
$142.94 |
| 83655 |
|
12 |
12 |
$141.00 |
| 83516 |
|
13 |
12 |
$108.25 |
| 82784 |
|
16 |
13 |
$87.37 |
| 84100 |
|
22 |
13 |
$84.84 |
| 87075 |
|
52 |
38 |
$65.84 |
| J3490 |
Unclassified drugs |
109 |
73 |
$45.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,624 |
3,388 |
$38.92 |
| 87205 |
|
52 |
38 |
$37.88 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,547 |
3,499 |
$28.97 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,272 |
4,918 |
$6.34 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,041 |
541 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
54 |
40 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
750 |
442 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
292 |
203 |
$0.00 |
| A9270 |
Non-covered item or service |
293 |
159 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
154 |
89 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
44 |
26 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
42 |
28 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
65 |
36 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
131 |
83 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
45 |
12 |
$0.00 |
| C1769 |
Guide wire |
19 |
16 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
21 |
12 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
83 |
65 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,619 |
1,034 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
511 |
355 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
76 |
25 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
46 |
28 |
$0.00 |
| 96523 |
|
19 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
18 |
12 |
$0.00 |